BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12421988)

  • 1. Tobacco reduces membrane HLA class I that is restored by transfection with transporter associated with antigen processing 1 cDNA.
    Fine CI; Han CD; Sun X; Liu Y; McCutcheon JA
    J Immunol; 2002 Nov; 169(10):6012-9. PubMed ID: 12421988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of antigen transport by expression of infected cell peptide 47 (ICP47) prevents cell surface expression of HLA in choriocarcinoma cell lines.
    Easterfield AJ; Austen BM; Westwood OM
    J Reprod Immunol; 2001 Apr; 50(1):19-40. PubMed ID: 11254939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA class I antigen downregulation by interleukin (IL)-10 is predominantly governed by NK-kappaB in the short term and by TAP1+2 in the long term.
    Terrazzano G; Romano MF; Turco MC; Salzano S; Ottaiano A; Venuta S; Fontana S; Manzo C; Zappacosta S; Carbone E
    Tissue Antigens; 2000 Apr; 55(4):326-32. PubMed ID: 10852384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of HLA class I downregulation in breast cancer by RT-PCR.
    Palmisano GL; Pistillo MP; Capanni P; Pera C; Nicolò G; Salvi S; Perdelli L; Pasciucco G; Ferrara GB
    Hum Immunol; 2001 Feb; 62(2):133-9. PubMed ID: 11182222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation.
    Barel MT; Ressing M; Pizzato N; van Leeuwen D; Le Bouteiller P; Lenfant F; Wiertz EJ
    J Immunol; 2003 Dec; 171(12):6757-65. PubMed ID: 14662880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetically coordinated induction of TAP1 and HLA class I by IFN-gamma: the rapid induction of TAP1 by IFN-gamma is mediated by Stat1 alpha.
    Min W; Pober JS; Johnson DR
    J Immunol; 1996 May; 156(9):3174-83. PubMed ID: 8617938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules.
    Jun Y; Kim E; Jin M; Sung HC; Han H; Geraghty DE; Ahn K
    J Immunol; 2000 Jan; 164(2):805-11. PubMed ID: 10623826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Construction of human TAP1 expression vector and the effects of it on HLA-I expression in GES-1 cells in vitro].
    Xing LX; Xing X; Wan XW; Xue LY; Zhang XH; Yan X; Wang JL
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Apr; 26(4):329-32. PubMed ID: 20368108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines.
    Singal DP; Ye M; Ni J; Snider DP
    Immunol Lett; 1996 May; 50(3):149-54. PubMed ID: 8803612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-F surface expression on B cell and monocyte cell lines is partially independent from tapasin and completely independent from TAP.
    Lee N; Geraghty DE
    J Immunol; 2003 Nov; 171(10):5264-71. PubMed ID: 14607927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12.
    Rotem-Yehudar R; Winograd S; Sela S; Coligan JE; Ehrlich R
    J Exp Med; 1994 Aug; 180(2):477-88. PubMed ID: 7519239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface expression of HLA-E molecules on PBMC from a TAP1-deficient patient.
    Furukawa H; Yabe T; Akaza T; Tadokoro K; Tohma S; Inoue T; Tokunaga K; Yamamoto K; Geraghty DE; Juji T
    Tissue Antigens; 1999 Mar; 53(3):292-5. PubMed ID: 10203023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Posttranscriptional regulation of human leukocyte antigen G during human extravillous cytotrophoblast differentiation.
    Copeman J; Han RN; Caniggia I; McMaster M; Fisher SJ; Cross JC
    Biol Reprod; 2000 Jun; 62(6):1543-50. PubMed ID: 10819754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.
    Seliger B; Harders C; Lohmann S; Momburg F; Urlinger S; Tampé R; Huber C
    Eur J Immunol; 1998 Jan; 28(1):122-33. PubMed ID: 9485192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of immunogenicity of a human renal-cell carcinoma cell line by TAP1-gene transfer.
    Kallfelz M; Jung D; Hilmes C; Knuth A; Jaeger E; Huber C; Seliger B
    Int J Cancer; 1999 Mar; 81(1):125-33. PubMed ID: 10077163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesis.
    Johnsen AK; Templeton DJ; Sy M; Harding CV
    J Immunol; 1999 Oct; 163(8):4224-31. PubMed ID: 10510359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of the expression of transports associated with antigen processing in human malignant melanoma increases tumor-specific immunity.
    Tao J; Li Y; Liu YQ; Wang L; Yang J; Dong J; Wu Y; Shen GX; Tu YT
    J Invest Dermatol; 2008 Aug; 128(8):1991-6. PubMed ID: 18385764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of sequences in the human peptide transporter subunit TAP1 required for transporter associated with antigen processing (TAP) function.
    Ritz U; Momburg F; Pircher HP; Strand D; Huber C; Seliger B
    Int Immunol; 2001 Jan; 13(1):31-41. PubMed ID: 11133832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors.
    Luckey CJ; Marto JA; Partridge M; Hall E; White FM; Lippolis JD; Shabanowitz J; Hunt DF; Engelhard VH
    J Immunol; 2001 Aug; 167(3):1212-21. PubMed ID: 11466336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.